BRIEF published on 03/31/2025 at 08:48, 8 months 4 days ago Grifols Biotest Holdings GmbH Announces Tender Offer for Biotest AG Tender Offer Biotest AG German Securities Grifols Acquisition Delisting Procedure
BRIEF published on 03/31/2025 at 08:48, 8 months 4 days ago Grifols Biotest Holdings GmbH annonce une offre publique d'achat sur Biotest AG Offre Publique D'achat Biotest AG Acquisition De Grifols Procédure De Radiation Titres Allemands
PRESS RELEASE published on 03/31/2025 at 08:43, 8 months 4 days ago EQS-WpÜG: Tender Offer / Target company: Biotest AG; Bidder: Grifols Biotest Holdings GmbH Grifols Biotest Holdings GmbH announces public delisting purchase offer for Biotest AG shares. Offering money in exchange. Details at https://www.grifols.com/en/biotest-acquisition-offer Shareholders Biotest AG Acquisition Offer Grifols Biotest Holdings GmbH Public Delisting Purchase Offer
Published on 12/05/2025 at 02:35, 4 hours 45 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 20 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 15 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 20 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 19 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 49 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 29 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 54 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 4 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 5 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 20 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 20 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 35 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 35 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
